| Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis W Van Rheenen, A Shatunov, AM Dekker, RL McLaughlin, FP Diekstra, ... Nature genetics 48 (9), 1043-1048, 2016 | 634 | 2016 |
| Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model HJ Westeneng, TPA Debray, AE Visser, RPA van Eijk, JPK Rooney, ... The Lancet Neurology 17 (5), 423-433, 2018 | 510 | 2018 |
| A proposal for new diagnostic criteria for ALS JM Shefner, A Al-Chalabi, MR Baker, LY Cui, M de Carvalho, A Eisen, ... Clinical Neurophysiology 131 (8), 1975-1978, 2020 | 485 | 2020 |
| Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology W Van Rheenen, RAA Van Der Spek, MK Bakker, JJFA Van Vugt, PJ Hop, ... Nature genetics 53 (12), 1636-1648, 2021 | 407 | 2021 |
| The chemotherapeutic oxaliplatin alters voltage-gated Na+ channel kinetics on rat sensory neurons H Adelsberger, S Quasthoff, J Grosskreutz, A Lepier, F Eckel, C Lersch European journal of pharmacology 406 (1), 25-32, 2000 | 402 | 2000 |
| Calcium dysregulation in amyotrophic lateral sclerosis J Grosskreutz, L Van Den Bosch, BU Keller Cell calcium 47 (2), 165-174, 2010 | 363 | 2010 |
| Neurofilament markers for ALS correlate with extent of upper and lower motor neuron disease K Poesen, M De Schaepdryver, B Stubendorff, B Gille, P Muckova, ... Neurology 88 (24), 2302-2309, 2017 | 247 | 2017 |
| Hot-spot KIF5A mutations cause familial ALS D Brenner, R Yilmaz, K Müller, T Grehl, S Petri, T Meyer, J Grosskreutz, ... Brain 141 (3), 688-697, 2018 | 233 | 2018 |
| Voltage-dependent block of neuronal and skeletal muscle sodium channels by thymol and menthol G Haeseler, D Maue, J Grosskreutz, J Bufler, B Nentwig, S Piepenbrock, ... European journal of anaesthesiology 19 (8), 571-579, 2002 | 227 | 2002 |
| Prefrontal and anterior cingulate cortex abnormalities in Tourette Syndrome: evidence from voxel-based morphometry and magnetization transfer imaging KR Müller-Vahl, J Kaufmann, J Grosskreutz, R Dengler, HM Emrich, ... BMC neuroscience 10, 1-13, 2009 | 219 | 2009 |
| Multicenter evaluation of neurofilaments in early symptom onset amyotrophic lateral sclerosis E Feneberg, P Oeckl, P Steinacker, F Verde, C Barro, P Van Damme, ... Neurology 90 (1), e22-e30, 2018 | 216 | 2018 |
| Widespread sensorimotor and frontal cortical atrophy in amyotrophic lateral sclerosis J Grosskreutz, J Kaufmann, J Frädrich, R Dengler, HJ Heinze, T Peschel BMC neurology 6, 1-10, 2006 | 201 | 2006 |
| A large-scale multicentre cerebral diffusion tensor imaging study in amyotrophic lateral sclerosis HP Müller, MR Turner, J Grosskreutz, S Abrahams, P Bede, V Govind, ... Journal of Neurology, Neurosurgery & Psychiatry 87 (6), 570-579, 2016 | 187* | 2016 |
| Towards a neuroimaging biomarker for amyotrophic lateral sclerosis MR Turner, J Grosskreutz, J Kassubek, S Abrahams, F Agosta, M Benatar, ... The Lancet Neurology 10 (5), 400-403, 2011 | 181 | 2011 |
| Effect of high‐caloric nutrition on survival in amyotrophic lateral sclerosis AC Ludolph, J Dorst, J Dreyhaupt, JH Weishaupt, J Kassubek, U Weiland, ... Annals of neurology 87 (2), 206-216, 2020 | 175 | 2020 |
| A randomized, double blind, placebo-controlled trial of pioglitazone in combination with riluzole in amyotrophic lateral sclerosis L Dupuis, R Dengler, MT Heneka, T Meyer, S Zierz, J Kassubek, ... PloS one 7 (6), e37885, 2012 | 158 | 2012 |
| Safety and effectiveness of long-term intravenous administration of edaravone for treatment of patients with amyotrophic lateral sclerosis S Witzel, A Maier, R Steinbach, J Grosskreutz, JC Koch, A Sarikidi, S Petri, ... JAMA neurology 79 (2), 121-130, 2022 | 152 | 2022 |
| Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study V Bril, A Drużdż, J Grosskreutz, AA Habib, R Mantegazza, S Sacconi, ... The Lancet Neurology 22 (5), 383-394, 2023 | 147 | 2023 |
| The ER mitochondria calcium cycle and ER stress response as therapeutic targets in amyotrophic lateral sclerosis V Tadic, T Prell, J Lautenschlaeger, J Grosskreutz FRONTIERS IN CELLULAR NEUROSCIENCE 8 (147), 2014 | 146 | 2014 |
| Assessment of the upper motor neuron in amyotrophic lateral sclerosis W Huynh, NG Simon, J Grosskreutz, MR Turner, S Vucic, MC Kiernan Clinical Neurophysiology 127 (7), 2643-2660, 2016 | 137 | 2016 |
Tino PrellHalle University HospitalEmail được xác minh tại uk-halle.de
